Literature DB >> 18166885

[Liver involvement in hemophagocytic syndrome].

Claire Larroche1, Marianne Ziol, Sémia Zidi, Robin Dhote, Dominique Roulot.   

Abstract

Hemophagocytic syndrome (HPS), whether familial or acquired, is a clinico-pathological entity, characterized by uncontrolled hyper-inflammation, leading sometimes to a lifethreatening condition. Liver dysfunction is central in HPS: hepatomegaly is discovered in half cases, liver enzyme elevation and/or cholestasis are very frequent, cholestasis is a prognostic factor, and liver biopsy is often necessary to confirm HPS and to diagnose the underlying disorders in secondary HPS. The spectrum is large from acquired SAM than can be cured with the treatment of his trigger, to genetic cases only cured by stem cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18166885     DOI: 10.1016/s0399-8320(07)78305-7

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  2 in total

1.  Haemophagocytic lymphohistiocytosis mimicking septic shock after the initiation of chemotherapy for squamous cell carcinoma of the neck.

Authors:  Madan Raj Aryal; Madan Badal; Smith Giri; Shambhu Aryal
Journal:  BMJ Case Rep       Date:  2013-06-27

2.  Hemophagocytic Lymphohistiocytosis (HLH) in Children Presenting as Liver Disease.

Authors:  Nomisha Amin; Ira Shah; Sushmita Bhatnagar
Journal:  J Clin Exp Hepatol       Date:  2013-07-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.